ADVANCED MALIGNANCIES
Clinical trials for ADVANCED MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MALIGNANCIES trials appear
Sign up with your email to follow new studies for ADVANCED MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Lifeline for cancer patients: continued access to promising drug
Disease control OngoingThis study offers continued treatment with avelumab for people with advanced cancers like lung, ovarian, or bladder cancer who are already benefiting from it in earlier Pfizer studies. The goal is to keep providing the drug and monitor safety and survival. About 68 participants w…
Matched conditions: ADVANCED MALIGNANCIES
Phase: PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated May 26, 2026 05:34 UTC
-
New PD-1 blocker shows promise in advanced cancer fight
Disease control OngoingThis study tested an experimental drug called PF-06801591, which helps the immune system attack cancer cells. It involved 155 adults with advanced solid tumors or non-small-cell lung cancer who had already tried other treatments. The goal was to check the drug's safety, how the b…
Matched conditions: ADVANCED MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated May 26, 2026 05:28 UTC
-
New drug AB598 takes first steps against advanced cancers
Disease control OngoingThis early-phase study tests a new drug called AB598, alone or with other treatments, in about 40 people with advanced solid tumors like lung, bladder, or ovarian cancer. The main goal is to check if the drug is safe and tolerable. Participants must have measurable tumors and be …
Matched conditions: ADVANCED MALIGNANCIES
Phase: PHASE1 • Sponsor: Arcus Biosciences, Inc. • Aim: Disease control
Last updated May 26, 2026 05:26 UTC
-
New immunotherapy combo shows promise for advanced lung cancer in early trial
Disease control OngoingThis early-phase study tests the safety and effectiveness of cemiplimab, an immunotherapy drug, alone or combined with other agents in Japanese patients with advanced lung cancer. The goal is to see if these treatments can shrink tumors by helping the immune system attack cancer …
Matched conditions: ADVANCED MALIGNANCIES
Phase: PHASE1 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 04:36 UTC
-
Cancer drug Follow-Up study seeks Long-Term safety answers
Disease control OngoingThis study looks at the long-term safety and effects of certain cancer drugs in people with advanced tumors. Participants must have already been in a related earlier study and still benefit from the treatment. The goal is to track side effects and see how well the drugs work over…
Matched conditions: ADVANCED MALIGNANCIES
Phase: PHASE3 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated May 18, 2026 12:12 UTC